Salarius Pharmaceuticals, Inc. logo

SLRXSalarius Pharmaceuticals, Inc.

SLRX Stock Price, Valuation & Chart | Salarius Pharmaceuticals, Inc.

Compare

SLRX Historical price chart

SLRX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization4.92M
PE Ratio-0.03
EPS-24.24
Trading Volume5.96M
Today's High/Low0.9/0.69
Dividend Yield0.00
52 Week High/Low52.95/0.52
Shares Outstanding5.86M
SLRX Financial Statement
SLRX Analyst ratings
SLRX Analysis & performance metrics

SLRX Company profile

Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat…

SLRX Management team

Management
Mark J. Rosenblum CPACFO
Executive Vice President of Finance & Chief Financial Officer
David J. Arthur M.B.A.CEO
Chief Executive Officer, President & Director
Total 2 executives

SLRX Frequently asked questions

What is Salarius Pharmaceuticals, Inc. (SLRX) Stock Price?

Current stock price of Salarius Pharmaceuticals, Inc. (SLRX) stock is $0.840. The stock price is +29.23% higher in the session. The intraday range can be seen from this page. Volume of Salarius Pharmaceuticals, Inc. (SLRX) stock is 5.96M.

Last updated at 07 Jan 2026, 09:00 pm.

Why is the Salarius Pharmaceuticals, Inc. (SLRX) stock price going up or down today?

The stock price of Salarius Pharmaceuticals, Inc. (SLRX) can change with earnings, company news, and overall market sentiment. Salarius Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Salarius Pharmaceuticals, Inc. stock expensive at its current price?

Whether Salarius Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SLRX on this page is -0.03. EPS on this page is -24.24. Compare those figures with peers and growth expectations before deciding if the current Salarius Pharmaceuticals, Inc. price is justified.

How has the stock price of Salarius Pharmaceuticals, Inc. (SLRX) performed historically?

Historical performance for Salarius Pharmaceuticals, Inc. (SLRX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SLRX reacted to past earnings and market events.

Should I buy Salarius Pharmaceuticals, Inc. (SLRX) stock, at this price?

Buying Salarius Pharmaceuticals, Inc. (SLRX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.